Saker Anwar Nusseibeh is CEO at FEDERATED HERMES, INC. (FHI). They have made 25 open-market trades across 1 company since 2020, most recently 2026-08-04.
CIK 0001744486
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 25 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| FHI | 144,246 | $8.1M |
| FII | 25,245 | $915K |
| Total | $9.0M |
Shares reported on the most recent Form 4, priced at the 2026-08-05 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| FHI | SELL | 2026-08-04 | 2026-08-05 | $64.24 | $452K | +0.2% | -2.6% | — |
| FHI | SELL | 2026-06-08 | 2026-06-09 | $57.34 | $513K | +4.3% | +2.2% | +6.7% |
| FHI | SELL | 2026-03-05 | 2026-03-06 | $56.50 | $348K | +1.7% | +4.6% | +3.5% |
| FHI | SELL | 2026-02-02 | 2026-02-03 | $53.66 | $311K | +4.8% | +7.5% | +2.1% |
| FHI | SELL | 2025-11-19 | 2025-11-20 | $47.85 | $427K | +6.0% | +12.2% | +17.5% |
| FHI | SELL | 2025-11-03 | 2025-11-03 | $48.55 | $1.5M | +0.5% | +3.4% | +9.7% |
| FHI | SELL | 2025-06-16 | 2025-06-17 | $42.70 | $512K | +5.8% | +12.3% | +25.9% |
| FHI | SELL | 2025-05-19 | 2025-05-20 | $43.09 | $635K | -1.0% | -0.2% | +24.4% |
| FHI | SELL | 2025-03-04 | 2025-03-06 | $37.57 | $520K | +1.5% | -6.5% | +9.4% |
| FHI | SELL | 2025-02-07 | 2025-02-10 | $38.81 | $430K | -0.9% | -1.2% | +12.7% |
| FHI | SELL | 2024-11-19 | 2024-11-20 | $41.38 | $369K | +2.2% | -1.2% | -7.3% |
| FHI | SELL | 2024-11-04 | 2024-11-04 | $39.86 | $969K | +5.2% | +7.2% | -1.4% |
| FHI | SELL | 2024-03-05 | 2024-03-07 | $36.15 | $600K | -0.7% | +3.0% | -8.7% |
| FHI | SELL | 2023-11-20 | 2023-11-21 | $31.87 | $584K | +2.0% | +7.3% | +11.1% |
| FHI | SELL | 2023-09-05 | 2023-09-06 | $34.73 | $271K | +0.3% | -0.9% | -8.5% |
| FHI | SELL | 2023-07-03 | 2023-07-03 | $36.10 | $3.1M | -1.7% | -6.9% | -8.0% |
| FHI | SELL | 2023-05-11 | 2023-05-12 | $37.48 | $1.5M | -5.0% | +0.2% | -11.4% |
| FHI | SELL | 2023-03-07 | 2023-03-07 | $39.12 | $777K | -1.1% | +0.4% | -10.3% |
| FHI | SELL | 2022-10-31 | 2022-10-31 | $34.85 | $498K | +1.8% | +8.5% | +9.8% |
| FHI | SELL | 2022-10-03 | 2022-10-03 | $33.49 | $1.0M | -4.5% | +3.4% | +11.4% |
| FHI | SELL | 2022-08-01 | 2022-08-01 | $34.29 | $240K | +0.6% | -0.6% | +1.4% |
| FHI | SELL | 2022-07-06 | 2022-07-07 | $32.24 | $1.7M | +1.5% | +2.5% | +0.0% |
| FHI | SELL | 2022-03-07 | 2022-03-08 | $30.96 | $558K | +8.3% | +3.7% | +10.1% |
| FHI | SELL | 2021-03-08 | 2021-03-09 | $30.11 | $307K | +0.8% | +3.5% | +8.2% |
| FHI | SELL | 2020-03-09 | 2020-03-09 | $24.43 | $104K | -22.5% | -16.7% | +10.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.